Project will use big data and analytics to address pressing public health issue
Bettis unveils new playbook for defending against severe allergic reactions and affected to take action
First patient enrolled in Phase III clinical trial for moxetumomab pasudotox as a treatment for unresponsive or relapsed hairy cell leukemia patients
Simponi has already been approved by the FDA for the treatment of moderately to severely active rheumatoid arthritis
Like a game of whack-a-mole, no matter how many times Johnson & Johnson attempts to put to rest lawsuits over the marketing of its Risperdal...
Time to stretch the legs?
Gilead Posts Higher Profit (Bloomberg News)
EU Rules Acomplia Isn't For The Depressed (TheStreet.com)
EU Backs Two Pfizer Drugs (Reuters)
